Wayne N. Burton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wayne N. Burton has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Alan Morrison
1 shared publicationAlyssa Schultz
1 shared publicationChen Yu Chin
1 shared publicationDee W. Edington
1 shared publication- Eric M. Ruderman
Department of Medicine, Division of Rheumatology, Feinberg School of Medicine Northwestern University Chicago Illinois
1 shared publication Ross Maclean
1 shared publication
Latest Publications
- Open Access
- 1 September 2010
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 37 (9) , 1792-1793
Work-associated Arthritis Productivity Loss: Where Do We Stand in Its Measurement?
- 1 September 2010
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 37 (9) , 1792-1793
Open AccessWork-associated Arthritis Productivity Loss: Where Do We Stand in Its Measurement?
- Open Access
- 11 November 2005
- Published by Oxford University Press (OUP) in Occupational Medicine
- Vol. 56 (1) , 18-27
Systematic review of studies of productivity loss due to rheumatoid arthritis
Background Rheumatoid arthritis (RA) is a chronic, debilitating disease with a significant impact on workplace productivity. Aim To perform a systematic review of studies of the relationship between RA and reduced workplace productivity. Methods Screening of 307 titles identified in bibliographic database searches resulted in 38 articles subject to systematic review. Productivity loss was expressed by three different measures: work disability, work loss (synonymous with absenteeism or short-term sick leave) and work limitation (reduction in productivity while present at work). Results A median of 66% (range 36–84%) of employed RA subjects experienced work loss due to RA in the previous 12 months, for a median duration of 39 days (range 7–84 days). The times from RA diagnosis until a 50% probability of being work disabled varied from 4.5 to 22 years. In inception cohort studies, the baseline variables consistently predictive of subsequent work disability were a physically demanding work type, more severe RA and older age. Conclusions RA-related work-disability rates were similar in the USA and European countries. An apparent decrease in the prevalence of RA-related work disability since the 1970s may be related to a decrease in physically demanding work rather than to epidemiologic changes in RA. The majority of the literature addresses permanent disability and temporary work loss; none of the studies reviewed reported the effect of RA on presenteeism, i.e. work limitation from the employer perspective, and there are few published studies of the effectiveness of disease-modifying anti-rheumatic drugs in reducing work-related productivity loss.
- 11 November 2005
- Published by Oxford University Press (OUP) in Occupational Medicine
- Vol. 56 (1) , 18-27
Open AccessSystematic review of studies of productivity loss due to rheumatoid arthritis
Background Rheumatoid arthritis (RA) is a chronic, debilitating disease with a significant impact on workplace productivity. Aim To perform a systematic review of studies of the relationship between RA and reduced workplace productivity. Methods Screening of 307 titles identified in bibliographic database searches resulted in 38 articles subject to systematic review. Productivity loss was expressed by three different measures: work disability, work loss (synonymous with absenteeism or short-term sick leave) and work limitation (reduction in productivity while present at work). Results A median of 66% (range 36–84%) of employed RA subjects experienced work loss due to RA in the previous 12 months, for a median duration of 39 days (range 7–84 days). The times from RA diagnosis until a 50% probability of being work disabled varied from 4.5 to 22 years. In inception cohort studies, the baseline variables consistently predictive of subsequent work disability were a physically demanding work type, more severe RA and older age. Conclusions RA-related work-disability rates were similar in the USA and European countries. An apparent decrease in the prevalence of RA-related work disability since the 1970s may be related to a decrease in physically demanding work rather than to epidemiologic changes in RA. The majority of the literature addresses permanent disability and temporary work loss; none of the studies reviewed reported the effect of RA on presenteeism, i.e. work limitation from the employer perspective, and there are few published studies of the effectiveness of disease-modifying anti-rheumatic drugs in reducing work-related productivity loss.